Aurora Cannabis vs Vanda Pharmaceuticals
Aurora Cannabis and Vanda Pharmaceuticals are similar in size: $232m and $216m of revenue in their latest fiscal years. Aurora Cannabis grew faster (11.7% against 8.7%). Aurora Cannabis kept more of each dollar of sales as profit: a net margin of -42.4% against -102.0%. Aurora Cannabis carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | Aurora CannabisACB, 2026 | Vanda PharmaceuticalsVNDA, 2025 |
|---|---|---|
| Revenue | $232m | $216m |
| Revenue growth | 11.7% | 8.7% |
| Net income | −$98.4m | −$220m |
| Operating margin | — | -70.0% |
| Net margin | -42.4% | -102.0% |
| Return on equity | -25.9% | -50.9% |
| Free cash flow | −$9.8m | −$110m |
| Cash | $46.4m | $84.9m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 533 |
| Market value | $295m | $225m |
| Price vs our value range | — | — |
| Moat score | — | 49 (Moderate) |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 6 sales |